Literature DB >> 8363706

Evidence for a membrane lipid defect in Alzheimer disease.

L Ginsberg1, J R Atack, S I Rapoport, N L Gershfeld.   

Abstract

We have previously shown that cells normally maintain their lipid metabolic pools at a critical composition, appropriate for spontaneous assembly of a stable membrane bilayer at their physiological temperature. When disease affects membrane lipids such that the new composition will only form a stable bilayer at a critical temperature (T*), which differs from the physiological value, membrane destabilization and hence cellular damage will necessarily ensue. We have previously tested this pathogenetic mechanism in metachromatic leukodystrophy, a disorder with a known primary lipid metabolic defect. In the present study, we found T* for cerebral cortex lipids from three Alzheimer disease (AD) patients ranged between 19 and 28 degrees C, independent of membrane protein composition. Control cortex lipids yielded a normal value for T* of 37 degrees C. Thus, one possible mechanism for neurodegeneration in AD is membrane destabilization secondary to a lipid compositional aberration, which shifts T* away from 37 degrees C. This lipid defect is brain region-specific as cerebellar lipids from the AD patients gave a normal value for T*. Studies aimed at delineating the nature of the biochemical anomaly are in progress.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8363706     DOI: 10.1007/bf03160167

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  9 in total

1.  Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammation.

Authors:  Chris J Reisenauer; Dhaval P Bhatt; Dane J Mitteness; Evan R Slanczka; Heidi M Gienger; John A Watt; Thad A Rosenberger
Journal:  J Neurochem       Date:  2011-02-24       Impact factor: 5.372

Review 2.  Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.

Authors:  A A Farooqui; S I Rapoport; L A Horrocks
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

3.  Effect of propylthiouracil-induced hypothyroidism on cerebral cortex of young and aged rats: lipid composition of synaptosomes, muscarinic receptor sites, and acetylcholinesterase activity.

Authors:  S Salvati; L Attorri; L M Campeggi; A Olivieri; M Sorcini; S Fortuna; A Pintor
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

4.  Neural membrane phospholipids in Alzheimer disease.

Authors:  K Wells; A A Farooqui; L Liss; L A Horrocks
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

5.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Authors:  K Hensley; J M Carney; M P Mattson; M Aksenova; M Harris; J F Wu; R A Floyd; D A Butterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

6.  Critical temperature for unilamellar vesicle formation in dimyristoylphosphatidylcholine dispersions from specific heat measurements.

Authors:  N L Gershfeld; C P Mudd; K Tajima; R L Berger
Journal:  Biophys J       Date:  1993-09       Impact factor: 4.033

7.  BACE1 RNAi Restores the Composition of Phosphatidylethanolamine-Derivates Related to Memory Improvement in Aged 3xTg-AD Mice.

Authors:  Javier G Villamil-Ortiz; Alvaro Barrera-Ocampo; Diego Piedrahita; Claudia M Velásquez-Rodríguez; Julian D Arias-Londoño; Gloria P Cardona-Gómez
Journal:  Front Cell Neurosci       Date:  2016-11-11       Impact factor: 5.505

Review 8.  HFE gene variants, iron, and lipids: a novel connection in Alzheimer's disease.

Authors:  Fatima Ali-Rahmani; Cara-Lynne Schengrund; James R Connor
Journal:  Front Pharmacol       Date:  2014-07-08       Impact factor: 5.810

Review 9.  Are Heat Shock Proteins an Important Link between Type 2 Diabetes and Alzheimer Disease?

Authors:  Joanne Elizabeth Rowles; Kevin Noel Keane; Thiago Gomes Heck; Vinicius Cruzat; Giuseppe Verdile; Philip Newsholme
Journal:  Int J Mol Sci       Date:  2020-11-02       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.